Table 3.
Details of patients with Staphylococcus lugdunensis bacteremia who had infective endocarditis or metastatic infections
| Sex, age (years) | Acquisition | Underling disease(s) | Devices | Methicillin susceptibility | Portal entry | Persistent bacteremia | Detail of infective endocarditis or metastatic infections | Source controla | Antibiotics therapy (days) | 30-day mortality |
|---|---|---|---|---|---|---|---|---|---|---|
| Male, 80 | Health care- associated | Thyroid cancer, rectal cancer, post AVR | Aortic valve | Susceptible | Unknown | Not persistent | Infective endocarditis (aortic valve) and Spondylitis | Replacement of aortic valve (two days) | Cefazolin (50) and Gentamicin (15) and Rifampicin (43) | Alive |
| Male, 74 | Hospital- acquired | Severe asthma, polymyositis (methylprednisolone 10 mg), SSS | Pacemaker | Susceptible | Unknown | Not persistent | Pacemaker related infective endocarditis (tricuspid valve) and Spondylitis | Eradicate of pacemaker, Tricuspid valve plasty (two days) | Cefazolin (42) | Alive |
| Female, 84 | Health care-associated | Hemodialysis, pancreas cancer, diabetes | Aortic valve | Resistant | Unknown | Persistent |
Infective endocarditis (aortic and mitral valves) CT or MRI were not done; thus, metastatic infection was not detected |
Not done | Vancomycin (8) and Levofloxacin (7) | Loss of follow up |
| Female, 69 | Hospital- acquired | Aortitis (prednisone 7 mg), cAVB, diabetes | Pacemaker, subclavian artery stent | Susceptible | Unknown | Persistent |
Psoas abscess, TEE was not done |
Not done | Cefazolin (47) | Alive |
| Male, 68 | Hospital- acquired | Liver cancer, diabetes | Blood accesses catheter | Resistant | Blood accesses catheter | Not persistent |
Liver and subcutaneous abscesses, TTE was not done |
Not done | Teicoplanin (25) | Alive |
Abbreviations: AVR Atrial valve replacement, TEE Transesophageal echocardiography, TTE Transthoracic echocardiography, cAVB Complete atrioventricular block, SSS Sick sinus syndrome, CT Computer tomography, MRI Magnetic resonance imaging
aSource control (Days to source control from blood culture collection)